This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This CTDSPL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 52-80 amino acids from the N-terminal region of human CTDSPL2.
CTDSPL2
Reaktivität: Human
WB, IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
FITC
Applikationshinweise
For WB starting dilution is: 1:1000
For FACS starting dilution is: 1:10~50
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
CTDSPL2
(CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase Like 2 (CTDSPL2))
D2Ertd485e antikoerper, RGD1309219 antikoerper, HSPC129 antikoerper, ctdspl2 antikoerper, ctdspl2a antikoerper, ctdspl2b antikoerper, hspc129 antikoerper, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 antikoerper, CTD small phosphatase like 2 antikoerper, CTD small phosphatase like 2 L homeolog antikoerper, CTD small phosphatase like 2 S homeolog antikoerper, Ctdspl2 antikoerper, CTDSPL2 antikoerper, ctdspl2.L antikoerper, ctdspl2.S antikoerper